← Open Payments lookup

MICHAEL KELLY: Open Payments

NPI 1740366111 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$916 in 86 payments from 10 companies in 2025. Trend: 2023 $1,236 · 2024 $1,284 · 2025 $916

Food & beverage: $816Education: $100
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.63$319
Janssen Biotech, Inc.6$230
PFIZER INC.3$78
ABBVIE INC.3$63
Ferring Pharmaceuticals Inc.3$57
COLOPLAST CORP3$56
UROGEN PHARMA, INC.2$44
Novartis Pharmaceuticals Corporation1$31
Boston Scientific Corporation1$20
Dendreon Pharmaceuticals LLC1$18

Products named: GEMTESA, ERLEADA, ORGOVYX, XTANDI, LUPRON DEPOT, ADSTILADRIN, Luja Coude, RYBREVANT.

Industry payments across OK — which companies pay providers there.